Max Robotics — Global Service Robot Directory + US Certification

About

Peter Dixon is a leading genetic epidemiologist whose work has fundamentally advanced our understanding of the genetic architecture of pregnancy-related liver disorders. His primary research focuses on intrahepatic cholestasis of pregnancy (ICP), a condition with a complex genetic etiology. Dixon’s landmark 2013 study, “A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy,” which has garnered over 120 citations, systematically dissected the role of canalicular transporter genes in ICP susceptibility. By moving beyond rare mutations to examine common genetic variants, he helped establish that the p.444A allele in ABCB11 acts as a population-level risk factor, not just a rare cause of disease. This work bridged a critical gap between Mendelian and complex disease genetics in hepatobiliary disorders. Dixon’s contributions have been instrumental in shaping how clinicians and researchers understand the polygenic nature of ICP, providing a framework for future risk stratification. His rigorous approach to candidate gene analysis remains a model for studying genetically heterogeneous conditions, cementing his reputation as a key figure in reproductive genetics and hepatology.